Clinical Trials in San Francisco

Showing 5241-5260 of 12,991 trials

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160

The primary objective of this study is to evaluate the long-term safety and efficacy of UX007 in participants with LC-FAOD. The secondary objectives of this study are to evaluate the effect of UX007 on energy metabolism in LC-FAOD and evaluate the impact of UX007 on clinical events associated with LC-FAOD.

Carnitine Palmitoyltransferase (CPT I or CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) DeficiencyLong-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency+2 more

Ultragenyx Pharmaceutical Inc94 participantsStarted Dec 2014

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Tampa, Florida, United States +8 more locations

Not Yet Recruiting< 1 mile

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

NCT05967481

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.

Neuroendocrine Tumors

Power Life Sciences Inc.500 participantsStarted Aug 2024

San Francisco, California, United States

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Find Trials by Condition in San Francisco

enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

Family Based Prevention of Alcohol and Risky Sex for Older Teens

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Evaluation Of New Onset Postoperative Atrial Fibrillation

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Family Health History in Diverse Care Settings (FHH)

FreeStyle Libre 3 Continuous Glucose Monitoring System

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

Decision Aids to Improve Knowledge in Patients With Prostate Cancer

Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)